Furthermore, immune checkpoint analysis revealed that ALDOA-high tumors exhibit reduced expression of key immune checkpoints, including PDCD1, CTLA4, and TIGIT, potentially reducing immune cell engagement with the tumor and further promoting immune evasion. This evidence concerns the gene TIGIT and neoplasm.